Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7750141 Modulation of apolipoprotein c-III expression

Patent 7750141 was granted and assigned to Ionis Pharmaceuticals on July, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

Ionis Pharmaceuticals

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Mark J. Graham0

Kenneth W. Dobie0

Rosanne M. Crooke0

Date of Patent

July 6, 2010

0

Patent Application Number

105537220

Date Filed

April 15, 2004

0

Patent Citations Received

US Patent 11851655 Compositions and methods for modulating apolipoprotein (a) expression

0

0

US Patent 11655291 Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and or activin A

0

Patent Primary Examiner

0

Patent abstract

Compounds, compositions and methods are provided for modulating the expression of apolipoprotein C-III. The compositions comprise oligonucleotides, targeted to nucleic acid encoding apolipoprotein C-III. Methods of using these compounds for modulation of apolipoprotein C-III expression and for diagnosis and treatment of disease associated with expression of apolipoprotein C-III are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7750141 Modulation of apolipoprotein c-III expression

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.